Q3 2025 DENTSPLY SIRONA Inc Earnings Call Transcript
Key Points
- Dentsply Sirona Inc (XRAY) has outlined a comprehensive 'Return to Growth' action plan focused on improving performance and delivering sustained profitable growth over the next 24 months.
- The company reported strong performance in its Wellspect business, which delivered 22.3% growth in the US and 5.3% in Europe on a constant currency basis.
- European sales increased by 9.9% as reported, driven by growth in Connected Technology Solutions and labs, with strong constant currency growth in the UK, France, Italy, and Spain.
- Dentsply Sirona Inc (XRAY) is making targeted investments in key areas to accelerate growth momentum in 2026, including increased R&D spending and clinical education for dental professionals.
- The company is focusing on empowering its people to power performance, with plans to strengthen its organizational foundation and enhance its enterprise AI and automation strategy.
- Global sales for Q3 2025 were $904 million, a decrease of 5% as reported, or negative 8% on a constant currency basis.
- US sales were down 22.2% versus the prior year, driven by lower sales in Essential Dental Solutions, ad camp, imaging, and implants.
- The company recorded a $263 million noncash after-tax charge related to the impairment of goodwill and intangible assets, driven by tariffs and lower projected volumes.
- Non-GAAP earnings per share decreased by $0.13 versus the prior year, with a higher non-GAAP tax rate impacting earnings.
- Dentsply Sirona Inc (XRAY) revised its 2025 outlook, with net sales expected to be in the range of $3.6 billion to $3.7 billion, reflecting a negative 5% to negative 4% year-over-year change on a constant currency basis.
Good day, and thank you for standing by. Welcome to the Q3 2025 DENTSPLY SIRONA earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Wade Moody, Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. Welcome to the DENTSPLY SIRONA's third-quarter 2025 earnings call. Joining me for today's call is Dan Scavilla, President and Chief Executive Officer. I'd like to remind you that an earnings press release and slide presentation related to the call are available in the Investors section of our website at www.dentsplysirona.com. Before we begin, please take a moment to read the forward-looking statements in our earnings press release.
During today's call, we may make certain forward-looking statements that reflect our current views about future performance and financial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
